Quest Diagnostics (DGX) Financials

Quest Diagnostics Inc (DGX) is a leading provider of diagnostic testing, information, and services. The company offers a wide range of laboratory tests and clinical services to healthcare providers, helping them make more informed decisions and improve patient care. With a strong focus on innovation and quality, Quest Diagnostics Inc (DGX) has established itself as a trusted partner in the healthcare industry.

The income statement of Quest Diagnostics Inc (DGX) provides important insights into the financial health of the company. It shows the company's revenue, expenses, and net income. In the latest fiscal year, the company reported total revenue of $7.7 billion, with a gross profit of $3.2 billion. The net income from stockholders was $685 million.

EBIT, or earnings before interest and taxes, is another key financial metric for Quest Diagnostics Inc (DGX). It measures the company's profitability before taking into account interest and tax expenses. In the latest fiscal year, the company reported EBIT of $1.1 billion.

EBITDA, or earnings before interest, taxes, depreciation, and amortization, is another important financial metric for Quest Diagnostics Inc (DGX). It provides a measure of the company's operating performance and cash flow generation. In the latest fiscal year, the company reported EBITDA of $1.7 billion.

The balance sheet of Quest Diagnostics Inc (DGX) provides a snapshot of the company's financial position at a specific point in time. It shows the company's assets, liabilities, and stockholders' equity. The total assets of the company were $11.4 billion, with total liabilities of $8 billion. The stockholders' equity was $3.4 billion.

Cash equivalents are highly liquid investments that can be readily converted into cash. They are an important component of a company's balance sheet, providing a measure of its liquidity. Quest Diagnostics Inc (DGX) reported cash equivalents of $340 million in the latest fiscal year.

Net debt is a measure of a company's overall debt position, taking into account both its short-term and long-term debt obligations. Quest Diagnostics Inc (DGX) reported net debt of $3.2 billion in the latest fiscal year.

Stockholders' equity represents the residual interest in the assets of a company after deducting its liabilities. It is a measure of the company's net worth or book value. Quest Diagnostics Inc (DGX) reported stockholders' equity of $3.4 billion in the latest fiscal year.

Total assets represent the total value of a company's resources or investments. It includes both tangible assets, such as buildings and equipment, and intangible assets, such as patents and trademarks. Quest Diagnostics Inc (DGX) reported total assets of $11.4 billion in the latest fiscal year.

Total debt represents the total amount of a company's borrowings and financial obligations. It includes both short-term borrowings, such as loans and credit lines, and long-term debt, such as bonds and mortgages. Quest Diagnostics Inc (DGX) reported total debt of $6.6 billion in the latest fiscal year.

Total liabilities represent a company's financial obligations and debts. They include both short-term liabilities, such as accounts payable and accrued expenses, and long-term liabilities, such as long-term debt and pension obligations. Quest Diagnostics Inc (DGX) reported total liabilities of $8 billion in the latest fiscal year.

The cash flow statement of Quest Diagnostics Inc (DGX) provides insights into the company's cash inflows and outflows during a specific period. It shows the company's operating cash flow, investing cash flow, and financing cash flow. In the latest fiscal year, the company reported operating cash flow of $1.5 billion, investing cash flow of $680 million, and financing cash flow of $837 million.

Free cash flow is another important financial metric for Quest Diagnostics Inc (DGX). It represents the cash left over after deducting capital expenditures from operating cash flow. In the latest fiscal year, the company reported free cash flow of $820 million.

Investing cash flow represents the cash used for investing activities, such as acquiring or disposing of assets, investing in securities, or making loans. Quest Diagnostics Inc (DGX) reported investing cash flow of $680 million in the latest fiscal year.

Operating cash flow represents the cash generated from the company's core operations, such as providing diagnostic testing and clinical services. Quest Diagnostics Inc (DGX) reported operating cash flow of $1.5 billion in the latest fiscal year.

In conclusion, the financial statements of Quest Diagnostics Inc (DGX) provide valuable information about the company's performance, profitability, and financial position. These statements help investors, analysts, and other stakeholders assess the company's financial health and make informed decisions.